The Frequency of Scleroderma Renal Crisis over Time: A Metaanalysis

被引:32
作者
Turk, Matthew [1 ]
Pope, Janet E. [2 ]
机构
[1] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada
[2] St Josephs Hlth Care, 268 Grosvenor St, London, ON N6A 4V2, Canada
关键词
SYSTEMIC SCLEROSIS; SCLERODERMA; RENAL CRISIS; TEMPORAL TREND; METAANALYSIS; SYSTEMIC-SCLEROSIS; SURVIVAL; MANIFESTATIONS; INVOLVEMENT; TRIALS; DEATH;
D O I
10.3899/jrheum.151353
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis ( SSc) leads to a high mortality from internal organ involvement. Scleroderma renal crisis ( SRC) usually occurs in the diffuse cutaneous SSc ( dcSSc) subset early in the disease, often with acute severe hypertension and renal failure. Prevalence of SRC since its classification in the early 1970s was determined in publications to assess whether the prevalence of SRC has changed over time because the proportion with the dcSSc subset is smaller in contemporary cohorts. Methods. A review of the literature was conducted up to May 2015 using the PubMed, EMBASE, CINAHL, and Cochrane Library databases. Articles were included if they mentioned the prevalence of SRC and were cohort or cross-sectional studies with 50 or more patients with SSc. Articles were excluded if they were not in English or were a case series of SRC or case-control studies. Results. Of the 5317 citations identified, 22 qualified. Years of publication were from 1983 to 2011, and cohort size varied from 68 to 8554 patients with SSc totaling 21,908 patients ( 9248 with dcSSc, 42%). There was no statistical reduction in the temporal prevalence of SRC noticed in the overall patients ( 4%), patients with dcSSc ( 7%-9%), or patients with limited cutaneous SSc ( lcSSc; 0.5%-0.6%) based on either the start date of the cohort or publication date. Conclusion. It appears that SRC remains uncommon in lcSSc and the rate in the dcSSc group may be stable over time. However, increasing awareness of SRC could lead to higher rates in more recent years and/or better survival from SRC, but this was not observed.
引用
收藏
页码:1350 / 1355
页数:6
相关论文
共 50 条
  • [41] Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility
    Penn, H.
    Quillinan, N.
    Khan, K.
    Chakravarty, K.
    Ong, V. H.
    Burns, A.
    Denton, C. P.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2013, 106 (09) : 839 - 848
  • [42] PERICARDIAL EFFUSION IS AN INDEPENDENT FACTOR PREDICTIVE OF SCLERODERMA RENAL CRISIS
    Fujisawa, Y.
    Hara, S.
    Zoshima, T.
    Ito, K.
    Mizushima, I.
    Fuji, H.
    Yamada, K.
    Kawano, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 428 - 429
  • [43] Systemic Sclerosis with Focus on Scleroderma Renal Crisis
    Pasha, Farahnaz
    Abazari, Setayesh
    Bikarannejad, Pouria
    Zabolian, Amirhossein
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2019, 13 (03) : 207 - 210
  • [44] Scleroderma Renal Crisis: Still a Lot To Do
    Codullo, Veronica
    Montecucco, Carlomaurizio
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (01) : 3 - 4
  • [45] New trends in the treatment of scleroderma renal crisis
    Shor, R
    Halabe, A
    NEPHRON, 2002, 92 (03): : 716 - 718
  • [46] Scleroderma renal crisis following silicone breast implant rupture: a case report and review of the literature
    Al Aranji, G.
    White, D.
    Solanki, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : 262 - 266
  • [47] Endothelin-1 and scleroderma renal crisis
    Terrier, B.
    Guillevin, L.
    Mouthon, L.
    REVUE DE MEDECINE INTERNE, 2007, 28 : S238 - S243
  • [48] Renal biopsy findings predicting outcome in scleroderma renal crisis
    Batal, Ibrahim
    Domsic, Robyn T.
    Shafer, Aaron
    Medsger, Thomas A., Jr.
    Kiss, Lawrence P.
    Randhawa, Parmjeet
    Bastacky, Sheldon
    HUMAN PATHOLOGY, 2009, 40 (03) : 332 - 340
  • [49] Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
    Alice Cole
    Voon H. Ong
    Christopher P. Denton
    Clinical Reviews in Allergy & Immunology, 2023, 64 : 378 - 391
  • [50] Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis
    Salituri, Jessica
    Patey, Natalie
    Takano, Tomoko
    Fiset, Pierre
    Del Rincon, Sonia
    Berkson, Laeora
    Baron, Murray
    Hudson, Marie
    Baron, M.
    Hudson, M.
    Gyger, G.
    Pope, J.
    Larche, M.
    Khalidi, N.
    Masetto, A.
    Sutton, E.
    Robinson, D.
    Rodriguez-Reyna, T. S.
    Smith, D.
    Thorne, C.
    Fortin, P. R.
    Fritzler, M.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (02) : 152 - 158